Characterization and Applications of New Hyper-Cross-Linked Cyclodextrins-Reference-Cited by-同舟云学术

Characterization and Applications of New Hyper-Cross-Linked Cyclodextrins

Published:2009-01 Issue:1 Volume:16 Page:39-48
ISSN:0927-6440
Container-title:Composite Interfaces
language:en
Short-container-title:Composite Interfaces

Author:

Trotta Francesco¹,Cavalli Roberta²

Affiliation:

1. a Dipartimento di Chimica I.F.M., Università degli Studi di Torino, Via Pietro Giuria 7, 10125 Torino, Italy

2. b Dipartimento di Scienza e Tecnologia del Farmaco, Università degli Studi di Torino, Via Pietro Giuria 9, 10125 Torino, Italy;, Email: roberta.cavalli@unito.it

Publisher

Informa UK Limited

Subject

Surfaces, Coatings and Films,General Physics and Astronomy,Ceramics and Composites

Link

https://www.tandfonline.com/doi/pdf/10.1163/156855408X379388

Reference14 articles.

1. Evaluation of cyclodextrin solubilization of drugs

2. Cyclodextrins and their uses: a review

3. Specific Antitumor Targetable β-Cyclodextrin−Poly(ethylene Glycol)−Folic Acid Drug Delivery Bioconjugate

4. Synthesis and characterisation of novel chemical conjugates based on α,β-polyaspartylhydrazide and β-cyclodextrins

5. Synthesis and characterization of a β-CD-alginate conjugate

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclodextrins: Establishing building blocks for AI-driven drug design by determining affinity constants in silico;Computational and Structural Biotechnology Journal;2024-12

2. Development and characterization of a cyclodextrin-based delivery system for enhanced pharmacokinetic and safety profile of oseltamivir;Journal of Inclusion Phenomena and Macrocyclic Chemistry;2024-09-09

3. Enhanced anticancer activity of N,N-bis(5-ethyl-2-hydroxybenzyl)methylamine (EMD) hydrophobic drug encapsulated in β-cyclodextrin nanosponges;Colloid and Interface Science Communications;2024-09

4. Appraisal terpenoids rich Boswellia carterri ethyl acetate extract in binary cyclodextrin oligomer nano complex for improving respiratory distress;Scientific Reports;2024-07-22

5. Preparation and Characterization of Iguratimod Oral Formulation Using IPNs of Carboxymethyl Tamarind Seed Gum and Cyclodextrin Nanosponges;Advances in Pharmacology and Pharmacy;2024-07